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Mobilization of naïve bone marrow mesenchymal stromal cells (BMSCs) is crucial to desired bone regeneration in both orthopedic
and dental contexts. In such conditions, mesenchymal progenitor cell populations from human exfoliated deciduous teeth (SHEDs)
present advantageous multipotent properties with easy accessibility which makes them a good candidate in both bone and
periodontal tissue regeneration. Extracellular vesicles (EVs) are a functional membranous structure which could participate in
multiple cell interactions and imitate the biological functions of their parenting cells largely. To assess their ability to mobilize
naïve BMSCs in the bone repair process, Nanosight Tracking Analysis (NTA) and Enzyme-Linked Immunosorbent Assays
(ELISA) were performed to illustrate the composition and functional contents of EV samples derived from SHEDs with different
culturing time (24 h, 48 h, and 72 h). Afterwards, the Boyden chamber assay was performed to compare their capacity for
mobilizing naïve BMSCs. One-way analysis of variance (ANOVA) with a post hoc Turkey test was performed for statistical
analysis. SHEDs-derived EVs collected from 24 h, 48 h, and 72 h time points, namely, EV24, EV48, and EV72, were mainly
secreted as exosomes and tended to reform into smaller size as a result of sonication indicated by NTA results. Moreover,
different EV groups were found to be abundant with multiple growth factors including transforming growth factor-β1 (TGF-
β1), platelet-derived growth factor (PDGF), insulin-like growth factor-1 (IGF-1), and fibroblast growth factor-2 (FGF-2) given
the detections through ELISA. Boyden chamber assays implied the migratory efficiency of BMSCs driven by EVs at varying
concentrations. However, the results showed that migration of BMSCs driven by different EV groups was not statistically
significant even with chemotactic factors contained (P > 0:05). Taken together, these data suggest that EVs derived from SHEDs
are secreted in functional forms and present a potential of mobilizing naïve BMSCs, which may propose their relevance in
assisting bone regeneration.
1. Introduction
Bone loss faces numerous challenges under diseased situa-
tions in both orthopedic and dental contexts. Autografts have
been recognized as the “gold standard” treatment for bone
defects; however, bone harvest volume is largely limited and
donor site morbidity is also reported [1, 2]. In oral tissue loss
scenarios, dental prostheses and implants can only relieve the
clinical symptoms but not impact the loss of bone and the
surrounding tissue. The process of natural bone repair is well
organized and precisely controlled by numerous molecular
signals. When a bone fracture occurs, a series of functional
factors including platelet-derived growth factor (PDGF),
transforming growth factor-β1 (TGF-β1), insulin-like
growth factors (IGFs), and fibroblast growth factor-2 (FGF-
2) is released into the extracellular space at the fracture site
[3–5]. These factors collectively mediate the mobilization of
bone marrow stromal cells (BMSCs), which proliferate and
subsequently differentiate into osteoblasts to contribute to
new bone formation. Stem cell transplantation has been
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shown to be effective for promoting the regenerative poten-
tial of bone in cases of nonunion fractures [6]. Nonetheless,
stem cell transplantation presents with caveats such as
immunosuppression and a depletion of oxygen and nutrients
to the microenvironment which makes it harsh for the naïve
progenitors to migrate through to the injured area [7]. There-
fore, the mobilization of naïve mesenchymal stromal cells
(MSCs) to target the injury site would rescue the insufficiency
of resident BMSCs and contribute to bone repair [8–10].
BMSCs are recognized multipotent cells, and their reparative
performance relies on the mobilization and migration to
target sites [11]. Their role in tissue regeneration relies on
the paracrine effects and directed differentiation, which is
dependent on the targeting migration to the relevant tissue
site. It has been noticed that bone marrow-derived multipo-
tent progenitor cells can produce therapeutic effects in a
paracrine manner through secretion of factors, rather than
engrafting or differentiating [12].
Regarding factors secreted, extracellular vesicles (EVs)
are gaining attention presently as they play a role in trans-
porting cargos of proteins and nucleic acids, namely, cell
messenger during biological processes. EVs are existing as
heterogeneous populations which can be characterized as
exosomes (30-100nm), microvesicles (100-1000 nm), and
apoptotic bodies (50 nm-2μm) depending on the size and
function according to definitions by the International Society
of the Extracellular Vesicles [13]. Studies have shown that
EVs are implicated in both physiological and pathological
processes, including stimulating specific and nonspecific
immune responses [14], inhibiting tumor growth [15], or
drug delivery [16]. Exogenous EVs derived from BMSCs
can be internalized by endogenous skeletal cells, thus initiat-
ing the differentiation of progenitor bone cells [17]. Together
with three-dimensional (3D) scaffolds, EVs have been
applied in bone engineering to repair large-scale bone
defects. It has been reported that engineered 3D polylactic
acid (PLA) scaffolds combined with human gingival stem
cells and EVs could produce enhanced bone and extracellular
matrix formation [18], which implied that EVs could boost
bone repair through internalization within the microenvi-
ronment and transporting functional cargos. EVs are also
known as functional vesicles with a performance of imitating
their parent cells [7]. As oral-derived stem cells showed
emerging benefits on stem cell therapy with easy accessibility
and multiple differentiation properties, mesenchymal pro-
genitor cell populations from human exfoliated deciduous
teeth (SHEDs) have been recognized as multipotent stem
cells with osteogenic and odontogenic potential, which could
be a significant origin of EVs as SHEDs could be obtained
through a technique that is painless and convenient with
greater proliferative capacity compared to dental pulp stem
cells (DPSCs), which is advantageous to repair bone and peri-
odontal tissues [19].
While these reports indicate the potential for EVs to
assist in driving osteogenic processes, knowledge of the
mechanisms for their role in bone repair is currently limited.
Therefore, we aimed to explore the potential role of EVs
derived from SHEDs in mobilizing BMSCs through detecting
the chemoattractant factors in EVs and the migration effi-
ciency produced by EVs. Our null hypothesis states that
EVs are unable to influence the migration of BMSCs. Con-
firming a chemoattractant role for these EVs may further
demonstrate their role in the bone repair process and poten-
tially be used to alleviate the clinical implications associated
with current treatment regimens.
2. Materials and Methods
2.1. EV-Depleted Medium Generation and SHED Cell
Culture. SHEDs were a generous gift from BioEden (BioE-
den, TX, USA). Cell culture medium was an EV-depleted
general medium, composed of Mesenchymal Stem Cell Basal
Media (Lonza, UK) supplemented with 15% EV-depleted
Fetal Bovine Serum (FBS) (Invitrogen, UK), 1% L-ascorbate
2-phosphate (Sigma-Aldrich, Poole, UK), 1% L-glutamine
(Invitrogen, UK), and 1% Antibiotic-Antimycotic (Invitro-
gen, UK). FBS was inactivated at 59.5°C for 30min, followed
by ultracentrifugation at 100,000 g for 18h at 4°C (Sorvall
Discovery 100SE, UK) and filtration of the resulting superna-
tant through a 0.2μmNalgene™ Rapid-Flow™ filter (Thermo
Fisher Scientific, UK) to obtain EV-depleted FBS. Upon
thawing, SHEDs were seeded into T175 culture flasks
(Sarstedt, Germany) at 10,000 cells/cm2 and incubated at
37°C, in 5% CO2 and 95% humidity, with medium changes
performed every 2-3 days.
2.2. EV Conditioned Medium (CM) Collection.When SHEDs
reached 80%-90% confluency, culture media were aspirated
and replaced with 20mL fresh culture media. Following this,
culture media were collected after 24 h, 48 h, and 72 h, which
were regarded as extracellular vesicle culture media (EVCM).
Three flasks of EVCM were collected for each group. EVCM
underwent a sequential centrifugation process of superna-
tants to purify EVs (400 g for 5min, 2,000 g for 15min,
10,000 g for 30min, and 100,000 g for 90min). The resulting
EV pellet after the final centrifugation step was resuspended
in 5mL of MEM (containing ribonucleosides and deoxyribo-
nucleosides (Thermo Fisher Scientific, UK)) prior to analyses
and utilization in this study, with EVs collected after 24 h,
48 h, and 72 h denoted as EV24, EV48, and EV72, respec-
tively. The supernatant from the final centrifugation step
for each EV group was retained for analysis and referred to
as top fraction (TF). EVs and TFs were stored at -80°C prior
to further analysis.
2.3. EV Sonication. 1mL of each EV group was maintained
on ice and sonicated (BRANSON Ultrasonics, USA) at
maximum intensity for 5 s, three times, with 5 s intervals.
EVs with different culture times after sonication were
denoted as EV24 SO, EV48 SO, and EV72 SO.
2.4. Nanoparticle Tracking Analysis (NTA). A nanoparticle
analysis system (NanoSight LM10 HS microscope, Nano-
Sight Ltd., Amesbury, UK) was used to analyze the abun-
dance and the size of EVs according to previously described
protocols [20, 21], corrected with α-MEM (Thermo Fisher
Scientific, UK) as reference diluent. Samples were thawed
and diluted in deionized distilled water at a dilution of
1 : 100 to achieve an approximated concentration between
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106 and 109 particles/mL to be analyzed. The particles were
detected using a 638 nm laser light, with 6 replicates
performed per analysis group. EVs were analyzed using
Nanoparticle Tracking Analysis 2.3 analytical software.
2.5. Chemotactic Factor Detection
2.5.1. Enzyme-Linked Immunosorbent Assay (ELISA).
Growth factors were detected in EV samples through com-
mercially available kits, following manufacturer protocols:
Human TGF-β1 Platinum ELISA kit (eBioscience, UK);
PDGF-BB and FGF-2 using respective Human Mini ELISA
kits (PeproTech, UK); Human IGF-1 Quantikine® ELISA
kit (R&D Systems, UK). Assays were performed in duplicate
on three separate occasions.
2.5.2. BMSC Culture and Fibronectin Selection. BMSCs were
commercially obtained (Lonza, UK), and fibronectin-
adherent BMSCs (FNA-BMSCs) were acquired as previously
described by Lee et al. [22]. FNA-BMSCs were plated into
tissue culture flasks (Sarstedt, Germany) at 5,000 cells/cm2 in
basal medium α-MEM supplemented with 10% FBS, 1% L-
ascorbate 2-phosphate (Sigma-Aldrich, Poole, UK), and 1%
Antibiotic-Antimycotic (Invitrogen, UK). FNA-BMSCs were
cultured at 37°C, 5% CO2 with media changed every 2-3 days.
2.5.3. Cell Migration Assay. The potential for SHED-derived
EVs to stimulate migration of FNA-BMSCs was performed
using a Boyden chamber assay, as previously described
[23]. EV concentration matched with the concentration of
TGF-β1 in 0.1μg/mL of demineralized dentin matrix
(DDM), which has been shown to effectively stimulate
FNA-BMSC migration [23], denoted as 1x. A tenfold lower
concentration was also used (denoted as 0.1x). Assays were
performed in triplicate and on three separate occasions.
2.6. Statistical Analysis. For all assays performed above, tripli-
cate samples were analyzed for each sample group (unless oth-
erwise mentioned), and assays were repeated on three separate
occasions. Statistical analyses to determine the analysis of
variance between sample groups were performed by one-
way ANOVA with a post hoc Tukey test using GraphPad
Prism 8 software (GraphPad, La Jolla, CA, USA). P < 0:05
was regarded as statistically significant.
3. Results
3.1. EV Analysis Using NTA. NTA was performed to analyze
the particle size and concentration [20]. Figures 1(a) and 1(b)
illustrate the concentrations of particles and the particle size,
corrected to EV-depleted media in all groups. All EV groups
showed a relative particle concentration. Moreover, the par-
ticle size of all of the groups was limited to 1000 nm, which
matched the particle size composition of EVs [24]. For both
unsonicated (EV) and sonicated (SO) groups, the highest
concentrations of particles were for EV72 and EV72 SO
groups. The peak concentration of particles in each group
varied in particle size. The particle size was predominantly
between 50 and 120nm [25], which refers to an exosome size.
The profile of size distribution was different for each time
point. For the EV groups, the particle concentration peaked
around 150-180nm for EV24, while EV48 and EV72 peaked
at 250-280nm and 210-230 nm, respectively. For the SO
groups, the distribution of particles was changed as a result
of sonication in all EV groups, where the number of particles
with the size over 300nm was reduced while that with the
size between 100nm and 300nm was increased.
3.2. Chemotactic Factor Quantification Using ELISA. The EV
samples were assayed for chemotactic factor concentration
by ELISA after sonication, in order to release their cargos
for analyses. Figures 2(a)–2(d) show the different concentra-
tions of TGF-β1, IGF-1, FGF-2, and PDGF-BB contained in
EV24, EV48, and EV72 groups. The concentrations were
corrected relative to -MEM. For TGF-β1, Figure 2(a) shows
that the highest concentration was present in EV48 at
2,556 pg/103 particles, which was significantly higher than
both EV24 and EV72 samples (P < 0:05). There was no
significant difference of TGF-β1 concentration between
EV24 and EV72 samples (P > 0:05). For IGF-1, Figure 2(b)
shows that EV24 and EV48 contain slightly higher IGF-1
than EV72 where there were no significant differences in
concentration between EV24, EV48, and EV 72 groups
(P > 0:05). For PDGF-BB, EV24 (79 pg/103 particles) and
EV48 (48 pg/103 particles) groups both demonstrated a
significantly greater concentration than EV72 (8 pg/103
particles) (P < 0:05). However, no difference in concentration
was observed between EV24 and EV48 groups (P > 0:05)
(Figure 2(c)). For FGF-2, the highest concentration (90pg/103
particles) was present in EV24 samples, which was signifi-
cantly higher than both EV48 and EV72 samples (P < 0:05)
(Figure 2(d)). There was no significant difference in FGF-2
concentration between EV48 and EV72 samples (P > 0:05).
3.3. Cell Migration Analysis. Boyden chamber assays were
performed to detect the migration potential of FNA-BMSCs
driven by unsonicated and sonicated EVs, based on the 1x
and 0.1x concentration of TGF-β1 required for BMSCmigra-
tion (15.6 pg/mL and 1.56 pg/mL, respectively), as demon-
strated previously [23]. EV groups were diluted into 1x and
0.1x with or without sonication in EV24, EV48, and EV72
groups. Serum-free media were used as a negative control.
Figure 3 shows the different fluorescent signals which resem-
bled the relative number of cells migrated through the
collagen-coated membranes. The different migratory activi-
ties were detected by comparing the migration relative to
the negative control. The migration efficiency among groups
was slightly improved driven by the EVs compared to
control, but it was not statistically significant (P > 0:05). SO
groups demonstrated slightly better chemotactic effects than
unsonicated groups in EV24 with (0.1x) or without (1x) dilu-
tion, while EVs without dilution (1x) showed slightly better
chemotactic efficiency in EV48 and EV72 groups towards
FNA-BMSCs.
4. Discussion
EVs have been described as important mediators during crit-
ical functional and biological processes among cells in disease
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contexts or tissue repair [26, 27]. Given the property of imi-
tating parent cells [28], the origin of EVs should be taken into
consideration. In the periodontal repair context, SHEDs were
previously explored with both bone and periodontal tissue
repair capacity. In an in vitro model, SHEDs present great
biological responses including cell viability and morphology
on silk fibroin scaffolds [29], which prepared SHEDs a prom-
ising candidate for tissue engineering. In a bone defect
model, SHED-derived conditioned media (SHED-CM) and
SHEDs were transplanted into the defect area and the osteo-
genic outcomes were compared. SHED-CM showed better
bone regeneration results with improved bone mineraliza-
tion and angiogenic potential [30]. Multiple cytokines were
also detected, aiming to elucidate the functional factors con-
tained in SHED-CM. It was reported that SHED-CM was
abundant in bone morphogenetic protein-2 (BMP-2),
BMP-4, and osteoprotegerin (OPG) and presented an anti-
inflammation performance [30, 31], suggesting that SHEDs
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Figure 1: (a) NTA results demonstrating the particle size distribution and concentrations of EVs in each group. Peak concentrations were at
particle sizes of approximately 179 nm, 255 nm, and 137 nm for EV24, EV48, and EV72 groups, respectively. (b) NTA results demonstrating
the particle size distribution and concentrations of EVs in each group after sonication. Peaks appear to be much less defined compared to
respective native EVs.
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As mobilizing BMSCs to the target site presents a critical
role in bone repair, in the present study, we hoped to illus-
trate how SHED-derived EVs perform for driving naïve
MSC migration where a series of detections was performed.
The NTA results provided an overall composition in terms
of the number and size of SHED-derived EVs. Most of the
EVs were in a diameter of 50-200 nm, suggesting that
SHED-derived EVs were mainly secreted as exosomes. The
NTA results also provided information regarding the sonica-
tion effects on EVs as the EVs are membrane vesicles that
need to be disrupted to release contents. With the sonication
performed, the mean particle size was reduced and the parti-
cles demonstrated a wider size distribution. This method
contributing to content release of EVs was also mentioned
by Haque et al. [32]. It was suggested that different types
and concentrations of the detergents would cause low disrup-
tion and reformation of the particles [32]; hence, sonication
was applied to disrupt EVs in this study.
To detect the chemotactic ability of SHED-derived EVs,
the chemotactic factors were investigated in the EV groups.
It is acknowledged that TGF-β1 is one of the most important
factors to drive MSC migration as well as IGF-1 [4, 33]. Both










































































































Figure 2: ELISA analyses of growth factors contained in EV groups, standardized per 1,000 particles. TGF-β1 concentration was significantly
higher for the EV48 group compared to EV24 and EV72 groups (a). IGF-1 concentration was unchanged between EV groups (b). FGF-2
concentration was shown to be higher in EV24 groups compared to EV48 and EV72 groups (c). The concentration of PDGF-BB was





















Figure 3: Cell migration efficiency of FNA-BMSCs induced by
different EV groups, relative to controls. No significant differences
were observed between groups. All of the data are presented as
mean ± SD.
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the concentration of PDGF-BB and FGF-2 was also detected
mostly in the EV24 group, compared to the EV48 and EV72
groups. As culturing time increased, EVs underwent subse-
quent uptake which possibly gave rise to their reduction in
the concentration of growth factors in EV48 and EV72
groups [13]. As the potential of EVs to drive MSC migration
has been mentioned in both bone repair and wound healing
scenarios [34, 35], cell migration assays were performed to
determine the chemotactic ability of SHED-derived EVs
towards BMSCs. In our research, the EV24 group showed
slight but not significantly different chemotactic potential
which was consistent with their wider composition of con-
tents, as EV24 are abundant with growth factors with more
diversity. However, the recruitment of MSCs was not signif-
icantly different among the groups according to the assays.
This indicates that the chemotactic factors contained in
EVs were still not sufficient to drive migration in our study.
According to the previous work by our group, the migration
process could be driven by DDM with more bioactive con-
tents, which also confirmed that the migratory process of
MSCs requires a cooperating work of multiple factors [23].
In our previous study, DDM in its 0.1μg/mL concentration
induced better cell migration compared to 10x or 100x higher
concentrations [23], which gives the idea that EVs require
optimization to more potent concentrations, and could be a
potential avenue for investigation in future work. Another
potential explanation is that the presence of additional
matrix components in DDM, which may not be present in
EVs, enhanced the migratory potential of chemotactic factors
at comparable concentrations [23]. Meanwhile, it was sug-
gested that the MSCs were more likely to migrate when there
is a stimulus present other than in a quiescent state [36]. In
fact, to mobilize more naïve MSCs to target sites, abundant
efforts were made in the past. It was reviewed that multiple
chemoattractants participate in the recruitment of MSCs
in vitro [37]. On the other hand, it is reported that the gradi-
ent sensitivity of the established assay would be too small to
drive obvious migration performance [34]. The migration
ability of MSCs also varies on properties including senes-
cence of stem cells and condition of the local stem cell niche
[38]. In such regard, the established assays for detecting the
chemotactic role of EVs derived from SHEDs should be opti-
mized in aspects of concentration, cooperating with other
chemoattractants, and passage of BMSCs used, which are
also the limitations in this research. Even though the EVs
carry functional cargos in our analysis, how they interact
with cells in the bone repair microenvironment inside the
body still requires further detection.
SHED-derived EVs abundant in exosomes contain
various cargos including chemotactic factors, giving rise to
the possibility to drive cell migration. This offers a chance
for SHED-derived EVs to mobilize more progenitor cells in
a bone repair context, and efforts could be made to promote
the bone healing process by stimulating the secretion of EV
cargos where EVs could function as a vehicle for a therapeu-
tic purpose [39]. Even these factors seem to be insufficient to
drive the migration of naïve BMSCs which might be because
multiple growth factor populations would work collectively
to mediate cell migration. Taken together, our results illus-
trated the potential of EVs originated from SHEDs to serve
as attractants of BMSCs, which was evident by heterogenous
growth factors contained whereas the ideal concentration of
EVs still required optimization in the future, particularly in
relation to other constituents which may or may not be pres-
ent in EV cargos, that influence the biological effects of
chemotactic factors.
Overall, our work contributes to a better understanding
of mobilizing BMSCs in a clinical context and the interac-
tions of EVs from SHEDs in the naïve bone repair microen-
vironment which may offer new treatment options for
hindered bone repair.
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